tiprankstipranks
Infinity Pharmaceuticals (INFIQ)
OTHER OTC:INFIQ
US Market

Infinity Pharmaceuticals (INFIQ) Financial Statements

912 Followers

Infinity Pharmaceuticals Financial Overview

Infinity Pharmaceuticals's market cap is currently $91.00. The company's EPS TTM is $; its P/E ratio is ―; Infinity Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 2.59M$ 1.86M$ 1.72M$ 3.05M
Gross Profit$ 1.03M$ 738.00K$ 682.00K$ -4.26M
Operating Income$ -44.84M$ -45.08M$ -38.50M$ -45.66M
EBITDA$ -43.73M$ -44.60M$ -37.56M$ -44.33M
Net Income$ -44.37M$ -45.26M$ -40.49M$ -47.06M
Balance Sheet
Cash & Short-Term Investments$ 38.31M$ 80.73M$ 34.11M$ 42.44M
Total Assets$ 42.15M$ 84.78M$ 39.32M$ 49.01M
Total Debt$ 48.13M$ 51.06M$ 24.33M$ 31.93M
Net Debt$ 9.82M$ -79.29M$ -4.26M$ 9.67M
Total Liabilities$ 61.20M$ 63.21M$ 62.31M$ 41.29M
Stockholders' Equity$ -19.05M$ 21.57M$ -22.99M$ 7.73M
Cash Flow
Free Cash Flow$ -42.45M$ -40.63M$ -35.78M$ -43.86M
Operating Cash Flow$ -42.43M$ -40.62M$ -35.74M$ -41.53M
Investing Cash Flow$ -55.00K$ 5.49M$ 14.63M$ -12.24M
Financing Cash Flow$ 73.00K$ 87.11M$ 27.44M$ 27.73M
Currency in USD

Infinity Pharmaceuticals Earnings and Revenue History

Infinity Pharmaceuticals Debt to Assets

Infinity Pharmaceuticals Cash Flow

Infinity Pharmaceuticals Forecast EPS vs Actual EPS